1) Nifepine
心痛定
1.
Prevention of Temporality Amaurosis due to Anesthesia behind the Eyeball with Nifepine before Operation of Late Stage Glaucoma;
晚期青光眼术前含服心痛定预防球后麻醉致一过性黑矇
2.
Curative Effects Observation of Nifepine on Cholecystalgia 42 Cases;
心痛定治疗胆绞痛42例疗效观察
3.
Objective To investigate effects of Nifepine on threatened erelnagune delivery.
目的探讨硝苯地平(心痛定)治疗先兆早产的临床疗效。
2) Nifedipine
[nə'fedipi:n]
心痛定
4) stable angina pectoris
稳定型心绞痛
1.
Study of Yixinshu capsule on stable angina pectoris which displaying deficiency of both vital energy and yin concurrently bleed stasis;
益心舒胶囊治疗气阴两虚兼血瘀证稳定型心绞痛的研究
2.
The Effect of Percutaneous Coronary Intervention on the Activities of Peripheral Blood Monocytes and Inflammation in Patients with Stable Angina Pectoris;
经皮冠状动脉介入治疗对稳定型心绞痛患者外周血单核细胞活性和炎症的影响
3.
The long-term anti-ischemic effect of isosorbide mononitrate in patients with chronic stable angina pectoris;
单硝酸异山梨酯对慢性稳定型心绞痛患者的长期抗缺血作用
5) Unstable angina
不稳定心绞痛
1.
High sensitivity C-reactive protein assays in serum of patients with unstable angina;
不稳定心绞痛患者血清超敏C反应蛋白检出的意义
2.
Defibrase in the treatment of coronary heart disease and unstable angina patients;
降纤酶在冠心病不稳定心绞痛患者中的应用
3.
Evaluation on hypersensitive C reaction protein as a prognostic marker for acute onset of unstable angina pectoris by ROC analysis;
应用ROC曲线评价C反应蛋白比值预测不稳定心绞痛急性发作的价值
6) stable angina pectoris
稳定性心绞痛
1.
Effect of Culiuhuangtong tablet on stable angina pectoris associated with hyper- lipem ia;
醋柳磺酮片治疗稳定性心绞痛合并高脂血症的疗效
2.
Clinical observation of cardiovascular accidents in patients with stable angina pectoris after joint replacement operation
稳定性心绞痛患者经骨科关节置换术治疗致心血管意外的临床观察
3.
ObjectiveTo investigate the effects of supplementing qi and activating blood circulation method (YQHX) on platelet aggregation rate (PAgR), platelet adhesion rate (PAdR) and thromboxane B2 (TXB2) level in patients with stable angina pectoris and intolerable to aspirin.
目的探讨益气活血法对稳定性心绞痛阿司匹林不耐受患者的血小板聚集率、黏附率及血栓素B2(thromboxane B2,TXB2)的影响。
补充资料：心痛定
分子式：C17H18N2O6
分子量：346.34
CAS号：21829-25-4
性质：黄色结晶。熔点172-174℃。易溶于丙酮、氯仿、乙酸乙酯，溶于热甲醇，不溶于水。遇光易变质。
制备方法：将邻硝基苯甲醛、乙酰乙酸甲酯、甲醇、氨水一起回流反应，然后冷冻、结晶，过滤得硝苯地平粗品。粗品用甲醇重结晶即得成品，收率50%。
用途：长效冠脉扩张药。本品能增加冠脉血流量，减少心肌耗氧量。用于急慢性冠脉功能不全，成其是心绞育及心肌梗塞。
分子量：346.34
CAS号：21829-25-4
性质：黄色结晶。熔点172-174℃。易溶于丙酮、氯仿、乙酸乙酯，溶于热甲醇，不溶于水。遇光易变质。
制备方法：将邻硝基苯甲醛、乙酰乙酸甲酯、甲醇、氨水一起回流反应，然后冷冻、结晶，过滤得硝苯地平粗品。粗品用甲醇重结晶即得成品，收率50%。
用途：长效冠脉扩张药。本品能增加冠脉血流量，减少心肌耗氧量。用于急慢性冠脉功能不全，成其是心绞育及心肌梗塞。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条